PMA

P900067: SULFUR HEXAFLUORIDE

FDA PMA · Gases used within eye to place pressure on detached retina · Airgas Therapeutics, LLC

Key facts

PMA number P900067
Trade name SULFUR HEXAFLUORIDE
Generic name Gases used within eye to place pressure on detached retina
Applicant Airgas Therapeutics, LLC
Owner/operator Airgas Therapeutics LLC
Product code LPO
Approval date Feb 25, 1993
Docket number 93M-0096
Notice date Apr 14, 1993
Establishment registration 2518435
FEI number 2518435

At a glance

  • 1–9 Supplements
  • Jan 20, 2012 Latest supplement decision
  • No Withdrawn
  • No Summary of safety and effectiveness on file
  • 1–9 UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals